A detailed medical and sexual medical historywas taken from individuals in the control and patient groups by applying the Golombok–Rust Inventoryof Sexual Satisfaction and Hospital Anxiety and Depression Scale.Results: Sexual frequency (p=0.027), impotence (p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Objective: We aimed to determine the prevalence of sexual dysfunction and clarify the relationship betweensexual dysfunction and depressive mood state, drugs, and disease activities in patients with predialyticchronic kidney disease (CKD).Materials and Methods: In total, 150 patients with CKD who had an estimated glomerular filtration rate of15–60 mL/min were included; 65 healthy controls were selected.
📊
Temel Bulgular & Veri:Objective: We aimed to determine the prevalence of sexual dysfunction and clarify the relationship betweensexual dysfunction and depressive mood state, drugs, and disease activities in patients with predialyticchronic kidney disease (CKD).Materials and Methods: In total, 150 patients with CKD who had an estimated glomerular filtration rate of15–60 mL/min were included; 65 healthy controls were selected.
💡
Sonuç & Katkı:A detailed medical and sexual medical historywas taken from individuals in the control and patient groups by applying the Golombok–Rust Inventoryof Sexual Satisfaction and Hospital Anxiety and Depression Scale.Results: Sexual frequency (p=0.027), impotence (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Objective: We aimed to determine the prevalence of sexual dysfunction and clarify the relationship betweensexual dysfunction and depressive mood state, drugs, and disease activities in patients with predialyticchronic kidney disease (CKD).Materials and Methods: In total, 150 patients with CKD who had an estimated glomerular filtration rate of15–60 mL/min were included; 65 healthy controls were selected. A detailed medical and sexual medical historywas taken from individuals in the control and patient groups by applying the Golombok–Rust Inventoryof Sexual Satisfaction and Hospital Anxiety and Depression Scale.Results: Sexual frequency (p=0.027), impotence (p
🔖
Bu Makaleye Atıf Yap
CETİNKAYA, R., SARI, F., GUVEN, S., INCI, A. (2022). Sexual Dysfunction Is Associated with Depression and Anxiety in Patients with Predialytic Chronic Kidney Disease. Eurasian Journal of Medicine, Cilt: 50 - Sayı: 2, 75–80. https://ajindex.com/articles/508986
Incidence and prevalence of ESRD. United States Renal Data System. Am J Kidney Dis 1998; 32(2 Suppl 1): 38-49.[CrossRef ] Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158: 825-30. [CrossRef ] Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altıparmak MR, et al. A population-based survey of Chronic Renal Disease In Turkey - the CREDIT study. Nephrol Dial Transplant 2011; 26: 1862-71. [CrossRef ] Soykan A, Boztas H, Kutlay S, Ince E, Nergizoglu G, Dileköz AY, Berksun O. Do sexual dysfunctions get better during dialysis Results of a sixmonth prospective follow-up study from Turkey. Int J Impot Res 2005; 17: 359-63. [CrossRef ] Levy NB, Wynbrandt GD. The Quality of life on maintenance hemodialysis. Lancet 1975; 305: 1328-30. [CrossRef ] Glaser GH. Brain dysfunction in uremia. Res Publ Assoc Nerv Ment Dis 1974; 53: 173-99.
Schmitz O, Moller J. Impaired prolactin response to arginine infusion and insulin hipoglycaemia in chronic renal failure. Acta Endocrinol (Copenh) 1983; 102: 486-91.
Sievertsen GD, Lim VS, Nakawate C, Frohman LA. Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab 1980; 50: 846-52. [CrossRef ] Navaneethan SD, Vecchio M, Johnson DW, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 2010; 56: 670-85. [CrossRef ] Foulks CJ, Cushner HM. Sexual dysfunction in the male dialysis patient: pathogenesis, evaluation and therapy. Am J Kidney Dis 1986; 8: 211-22. [CrossRef ] Esen B, Kahvecioğlu S, Altay AE, et al. Evaluation of relationship between sexual functions, depression and quality of life in patients with chronic kidney disease at predialysis stage. Ren Fail 2015; 37: 262-7. [CrossRef ] Rust J, Golombok S. The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav 1986; 15: 157–65. [CrossRef ] Zigmond AS, Snaith PR. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–70. [CrossRef ] Procci WR, Goldstein DA, Adeistein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int 1981; 19: 317- 23. [CrossRef ] Carson CC, Patel MP. The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients.